General Information of the Compound
Compound ID
CP0508655
Compound Name
benzo[b][1]benzazepin-11-yl-(4-hydroxypiperidin-1-yl)methanone
    Show/Hide
Structure
Formula
C20H20N2O2
Molecular Weight
320.392
Canonical SMILES
OC1CCN(CC1)C(=O)N1c2ccccc2C=Cc2ccccc12
    Show/Hide
InChI
InChI=1S/C20H20N2O2/c23-17-11-13-21(14-12-17)20(24)22-18-7-3-1-5-15(18)9-10-16-6-2-4-8-19(16)22/h1-10,17,23H,11-14H2
    Show/Hide
InChIKey
NHQRIFAVIPFQMU-UHFFFAOYSA-N
Physicochemical Property
logP
3.8852
Rotatable Bonds
0
Heavy Atom Count
24
Polar Areas
43.78
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 76321049
ChEMBL ID
CHEMBL3103380
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02908, P2X purinoceptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS